Cited by 386Adrenal Hormones and DisordersHormonal and reproductive studiesStress Responses and Cortisol

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Improvement in Mood and Fatigue after Dehydroepiandrosterone Replacement in Addison’s Disease in a Randomized, Double Blind Trial

Hunt, Penelope J., Gurnell, Eleanor M., Huppert, Felicia A., Richards, Christine, Prevost, A. Toby, Wass, John A. H., Herbert, Joseph, Chatterjee, V. Krishna K.·2000·The Journal of Clinical Endocrinology & Metabolism

Abstract

Dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS) are adrenal precursors of steroid biosynthesis and centrally acting neurosteroids. Glucocorticoid and mineralocorticoid deficiencies in Addison's disease require life-long hormone replacement, but the associated failure of DHEA synthesis is not corrected. We conducted a randomized, double blind study in which 39 patients with Addison's disease received either 50 mg oral DHEA daily for 12 weeks, followed by a 4-week washout period, then 12 weeks of placebo, or vice versa. After DHEA treatment, levels of DHEAS and Delta(4)-androstenedione rose from subnormal to within the adult physiological range. Total testosterone increased from subnormal to low normal with a fall in serum sex hormone-binding globulin in females, but with no change in either parameter in males. In both sexes, psychological assessment showed significant enhancement of self-esteem with a tendency for improved overall well-being. Mood and fatigue also improved significantly, with benefit being evident in the evenings. No effects on cognitive or sexual function, body composition, lipids, or bone mineral density were observed. Our results indicate that DHEA replacement corrects this steroid deficiency effectively and improves some aspects of psychological function. Beneficial effects in males, independent of circulating testosterone levels, suggest that it may act directly on the central nervous system rather than by augmenting peripheral androgen biosynthesi…

Overview

Integrity signals

Registry

Crossref · 10.1210/jcem.85.12.7022

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 11 references

Research works printed but not linked: 27

  1. Butenandt, 1934, Isolierung neuen, physiologisch unwirksamen Sterindervates aus Mannerharn, Seine Verknupfung mit Dehdro-androsterone und Androsteron., Z Physiol Chem, 229, 192, 10.1515/bchm2.1934.229.4-6.192 · DOI
  2. Roberts, 1987, Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice., Brain Res, 406, 357, 10.1016/0006-8993(87)90807-9 · DOI
  3. Bologa, 1987, Dehydroepiandrosterone, its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures., J Neurosci Res, 17, 225, 10.1002/jnr.490170305 · DOI
  4. Newcomer, 1994, Glucocorticoid-induced impairment in declarative memory performance in adult humans., J Neurosci, 14, 2047, 10.1523/JNEUROSCI.14-04-02047.1994 · DOI · Paper page
  5. Landfield, 1978, Hippocampal aging and adrenocorticoids: quantitative correlations., Science, 202, 1098, 10.1126/science.715460 · DOI
  6. Starkman, 1981, Neuropsychiatric manifestations of patients with Cushing’s syndrome: relationship to cortisol and adrenocorticotrophic hormone levels., Arch Intern Med, 141, 215, 10.1001/archinte.1981.00340020077021 · DOI · Paper page
  7. Shafagoj, 1992, Dehydroepiandrosterone prevents dexamethasone-induced hypertension in rats, Am J Physiol., 263, E210
  8. Kimonides, 1999, Dehydroepiandrosterone (DHEA) antagonises the neurotoxic effects of corticosterone, translocation of SAPK 3 in hippocampal primary cultures., Neuroscience, 89, 429, 10.1016/S0306-4522(98)00347-9 · DOI
  9. Parker, 1978, The adrenarche: prolactin, gonadotropins, adrenal androgens and cortisol., J Clin Endocrinol Metab, 46, 396, 10.1210/jcem-46-3-396 · DOI
  10. Orentreich, 1984, Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood., J Clin Endocrinol Metab, 59, 551, 10.1210/jcem-59-3-551 · DOI · Paper page
  11. Barrett-Connor, 1986, A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease., N Engl J Med, 315, 1519, 10.1056/NEJM198612113152405 · DOI · Paper page
  12. Sambrook, 1992, Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens., J Rheumatol, 19, 357
  13. Morales, 1994, Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age., J Clin Endocrinol Metab, 78, 1360
  14. Diamond, 1996, Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women, J Endocrinol., 150, S43
  15. Casson, 1998, Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-1 and decreases high-density lipoprotein: a six month trial., Fertil Steril, 70, 107, 10.1016/S0015-0282(98)00121-6 · DOI
  16. Reidel, 1993, Quality of life in patients with Addison’s disease: effects of different cortisol replacement modes., Exp Clin Endocrinol, 101, 106, 10.1055/s-0029-1211215 · DOI
  17. Cheetham, 1998, The effects of recombinant human IGF-1 administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-1, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus., J Endocrinol, 157, 81, 10.1677/joe.0.1570081 · DOI
  18. Goodyer, 1996, Adrenal secretion during major depression in 8- to 16- year olds. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation., Psychol Med, 26, 245, 10.1017/S0033291700034644 · DOI
  19. Guazzo, 1996, Cortisol, dehydroepiandrosterone (DHEA), DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age., J Clin Endocrinol Metab, 81, 3951
  20. Rust, 1986, The GRISS: a psychometric instrument for the assessment of sexual dysfunction., Arch Sex Behav, 15, 157, 10.1007/BF01542223 · DOI
  21. Young, 1997, Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans., J Clin Endocrinol Metab, 82, 2578
  22. Arlt, 1999, Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens., J Clin Endocrinol Metab, 84, 2170, 10.1210/jcem.84.6.5789 · DOI
  23. May, 1991, Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone., Life Sci, 46, 1627
  24. Wright, 1992, Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats., Int J Obesity, 16, 579
  25. Davis, 1996, Clinical review: androgens and the postmenopausal woman., J Clin Endocrinol Metab, 21, 227
  26. Kalmijn, 1998, A prospective study on cortisol, dehydroepiandrosterone sulfate and cognitive function in the elderly., J Clin Endocrinol Metab, 83, 3487, 10.1210/jcem.83.10.5164 · DOI
  27. Baulieu, 2000, Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue., Proc Natl Acad Sci USA, 97, 4279, 10.1073/pnas.97.8.4279 · DOI · Paper page

Cited by

Sorted by citations

See all 386

Metadata

Authors
Hunt, P. J., Gurnell, E. M., Huppert, F. A., Richards, C., Prevost, A. T., Wass, J. A. H., Herbert, J., & Chatterjee, V. K. K.
Affiliations
  • University of Oxford (GB)
  • University of Cambridge (GB)
  • Community Medicine (A.T.P.), Cambridge, United Kingdom CB2 2QQ
  • Departments of Medicine (E.M.G., C.R., V.K.K.C.), Cambridge, United Kingdom CB2 2QQ
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2000-12-01
Volume
85
Issue
12
Pages
4650-4656
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2138758697
Cited by
386
References
45
Citations by year
2026: 2 · 2025: 1 · 2024: 8 · 2023: 3 · 2022: 6 · 2021: 9 · 2020: 58 · 2019: 1 · 2018: 7 · 2017: 4 · 2016: 10 · 2015: 13 · 2014: 15 · 2013: 5 · 2012: 12
FWCI
16.47
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
Hologic
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
dehydroepiandrosterone, Addison's disease, DHEA replacement therapy, DHEA sulfate, adrenal insufficiency, mood, fatigue, self-esteem, well-being, testosterone, sex hormone-binding globulin, androstenedione, neurosteroids, central nervous system effects, glucocorticoid deficiency, mineralocorticoid deficiency
MeSH terms
Addison Disease, Adult, Affect, Aged, Body Composition, Cognition, Dehydroepiandrosterone, Double-Blind Method, Fatigue, Female, Hormones, Humans, Male, Middle Aged, Sexual Behavior, Bone Density, Cross-Over Studies, Dehydroepiandrosterone Sulfate, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improvement in Mood and Fatigue after Dehydroepiandrosterone Replacement in Addison’s Disease in a Randomized, Double Blind Trial. https://app.cochat.ai/papers/10.1210/jcem.85.12.7022
The paper
Hunt, P. J., Gurnell, E. M., Huppert, F. A., Richards, C., Prevost, A. T., Wass, J. A. H., Herbert, J., & Chatterjee, V. K. K. (2000). Improvement in Mood and Fatigue after Dehydroepiandrosterone Replacement in Addison’s Disease in a Randomized, Double Blind Trial. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem.85.12.7022